Dr. Annageldiyev is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 UNIVERSITY DR
Hershey, PA 17033Phone+1 717-531-0003
Education & Training
Penn State Milton S Hershey Medical CenterFellowship, Hematology and Medical Oncology, 2022 - 2026- Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2020 - 2022
- Penn State Milton S Hershey Medical CenterPost-Doctoral Fellowship, Hematology and Medical Oncology, 2016 - 2020
OtherClass of 2015, MD, Meram School of Medicine
Certifications & Licensure
PA State Medical License 2020 - 2024- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow of the year Penn State University, Department of Medicine, 2023
- Bradley and Bond Travel Award Penn State College of Medicine, 2019
- Best Research Award Penn State Cancer Institute, 2018
Publications & Presentations
PubMed
- 1 citationsActivation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells.Fenghua Qian, Shaneice K Nettleford, Jiayan Zhou, Brooke E Arner, Molly A Hall
Cell Reports. 2023-07-25 - 3 citationsCD26PD-1CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia.Huarong Zhou, Bei Jia, Charyguly Annageldiyev, Kentaro Minagawa, Chenchen Zhao
Frontiers in Immunology. 2023-01-01 - 9 citationsCeramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia.Andrei V Khokhlatchev, Arati Sharma, Tye G Deering, Jeremy J P Shaw, Pedro Costa-Pinheiro
FASEB Journal. 2022-10-01
Journal Articles
- A Xenograft Mouse Model to Assess Efficacy of Therapeutic Agents for Human Acute LeukemiaChandrika Gowda*, Charyguly Annageldiyev*, Pavan Kumar Dhanyamraju, Morgann Klink, Sinisa Dovat, Mark Kester, Thomas P. Loughran, Jr, David Claxton, Arati Sharma, JOVE, 3/1/2020
Books/Book Chapters
Press Mentions
"Don't be like patient 31": How a person plunged South Korea deep into the crisisMay 5th, 2020
Research History
- Developing Patient-Derived Xenograft (PDX) models in Acute Leukemia2018 - Present
- Developing novel therapeutics against Cancer stem cells2016 - Present
- Targeting Sphingolipid Metabolism for treatment of AML2016 - 2020
Professional Memberships
- Member
- Member
- Member
External Links
- Google Scholarhttp://scholar.google.com/citations?user=R1Q4bTIAAAAJ&hl=en&oi=ao
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
